openPR Logo
Press release

Antihypertensive Drugs Market - Positive long-term growth outlook 2023

08-03-2017 02:29 PM CET | Health & Medicine

Press release from: Transparency Market Research

Antihypertensive Drugs Market

Antihypertensive Drugs Market

Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to various other problemssuch as renal impairment, visual impairment, heart failure and retinal hemorrhage. According to the World Health Organization (WHO), 7.5 million deaths globally are caused due to hypertension, and it accounts to 12.8% of the total deaths. Globally,in 2008 prevalence of hypertension was observed to be around 40% in adults aged 25. According to the National Health and Nutrition Evaluation Survey, ithas been noted that in United States from 2007 to 2010,81.5% of the population is aware of their hypertension condition, out of which 74% are being treated and only 52.5% are under control.

This report gives readers a comprehensive overview of the Antihypertensive Drugs Market:
http://www.transparencymarketresearch.com/antihypertensive-drugs-market.html

Theantihypertensive drugs market based on the therapy area is classified into diuretics (hydrochlorothiazide and indapamide), calcium channel blockers (nifedipine, felodipine and diltiazem), angiotensin receptor blockers or ARBs (losartan), angiotensin converting enzyme (ACE)inhibitors (captopril, lisinopril and perindopril), beta blockers vasodilators (atenolol and propranolol), alpha blockers (clonidine, guanabenz), and renin inhibitors.Diuretics being the first line of treatment for hypertension holds the major share of the market. All these drug classes (drugs) have shown to reduce cardiovascular morbidity and mortality. The drugs are administered either as a single or combined dose depending upon the stage of hypertension, whilethe choice of drugs depends upon the patients’ medical history and current conditions.

On the basis of the geography, the antihypertensive market can be segmented into North America, Europe, AsiaPacific, Latin America, and Middle East and Africa.The global antihypertensive market is dominated mainly by North America and Europe. According to the WHO, the prevalence of hypertension is highest in Africa and lowest in Americas. In Africa more than 40% of the adults suffer from hypertension and many of them remain undiagnosed due to the high cost of medications.The increased genericization by the local companies can be a challenge for the market. Similarly, in recent years, there has beena significant improvement in the management of hypertension contributing to a strong decline in the death rates in North America and Western Europe.

Get accurate market forecast and analysis on the Antihypertensive Drugs Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7718

The change in lifestyle, elevated stress level, and rise in prevalent population, early detection and penetration of combined dose would be the main factors to drive the growth of antihypertensive market. The patent expiry for major drugs such as Diovan (Novartis), Cozaar (Merck),Revatio (Pfizer), Exforge (Novartis), Atacand (AstraZeneca), Avapro (Sanofi Aventis), BIopress(Takeda) and Benicar (Daiichi Sankyo), along with low diagnostics rate and increased generic penetration would result in the antihypertensive market slowdown, but the novel antihypertensive drugs in the pipeline can recover the losses of patent expiration.

Some of the major key players in the global antihypertensive market includes Novartis AG, Pfizer Inc., Sanofi S.A, Johnson & Johnson Ltd., Daiichi - Sankyo, Merck & Co., AstraZeneca Plc.,Ranbaxy Laboratories Limited and Lupin Limited.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antihypertensive Drugs Market - Positive long-term growth outlook 2023 here

News-ID: 653361 • Views: 166

More Releases from Transparency Market Research

Monochloroacetic Acid Market Demand, Prominent Players and Growth By 2027
Albany, NY - The global monochloroacetic acid market was valued at US$ 815.74 Mn in 2018 and is anticipated to expand at a CAGR of approximately 4.0% during the forecast period, according to a new report titled ‘Monochloroacetic Acid Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’ published by Transparency Market Research (TMR) The report infers to the usage of monochloroacetic acid for oil drilling activities. Asia Pacific is
Polyethylene Furanoate (PEF) Market Poised to Expand at a Robust Pace Over 2019- …
Polyethylene Furanoate (PEF) Market: Bio-based Substitute for Polyethylene Terephthalate • Polyethylene Furanoate (PEF) is commonly called as the next generation polyester. It has the capability to replace polyethylene terephthalate (PET). PET is a durable polymer derived from conventional synthetic resources. • PEF is manufactured by polymerization of furandicarboxylic acid (FDCA) in the presence of ethylene glycol. FDCA is produced by using raw materials such as starch, sugar, and cellulose. These materials are extensively produced
Miso Market Estimated to Experience a Hike in Growth by 2020-2030
Global Miso Market: Overview The demand within the global miso market is set to touch unprecedented levels in the times to come by. The growing popularity of cultural foods has given an impetus to the expansion of the miso market. Besides, the taste imparted by miso to several traditional dishes has created humongous opportunities for growth across the global miso market. The next decade could witness the perfecting of several recipes
Walnut Market Set to Witness an Uptick during 2020 to 2030
Global Walnut Market: Snapshot Recent lifestyle shifts have led people to look for options that are packed with essential nutrients. And, the search has led them to superfoods. And, nuts are particularly known to be super-effective in this domain. Considering, that just a handful is sufficient in to cover a significant portion of daily calorific intake and a respectable portion of minerals and vitamins. And, walnut are no different. Rich in

All 5 Releases


More Releases for Antihypertensive

Antihypertensive Drugs Market Growth, Industry Analysis, Trends and Forecast - 2 …
Antihypertensive Market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2025, registering a CAGR of 3% from 2019 to 2025. Antihypertensive drugs are used in the treatment of hypertensive patients. High blood pressure is a medical condition that involves elevated blood pressure in the arteries. Additionally, patients suffering from high blood pressure are very susceptible to other complications such as heart failure and aneurysms. Therefore,
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best
Antihypertensive Market : Industry to Witness Fastest Growth by 2023
Antihypertensive is a treatment for hypertension. The increase in blood pressure is also referred to as arterial hypertension because it is measured by blood on the arterial wall in terms of systolic and diastolic blood pressure. Antihypertensive agents relieve complications of stroke and myocardial infarction. Lowering blood pressure can minimize the risk of death from heart attack, ischemic heart disease, dementia and hypertension. Lifestyle changes are a major factor in
Antihypertensive Drugs Market Growth and Forecast 2015 - 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to
Global Antihypertensive Drugs Market US$ 24.3 Billion 2021
The global antihypertensive drugs market expected to reach US$ 24.3 billion by 2021, steadily declining at CAGR 2.5% over the forecast period 2017-2021, mainly due to patent expiration of blockbuster drugs and increasing generic competition worldwide. Antihypertensive drugs are used to treat high blood pressure and its complications, such as stroke and myocardial infarction. The most important and most widely used drugs include thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin
Antihypertensive Drugs Market : Opportunities and Forecasts upto 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to